Evidence map›Paper›PMID 36893126›Full record

ArticlePloS one2023

A marmoset model for Mycobacterium avium complex pulmonary disease.

Jay Peters, Diego Jose Maselli, Mandeep Mangat, Jacqueline J Coalson, Cecilia Hinojosa, Luis Giavedoni, Barbara A Brown-Elliott, Edward Chan, David Griffith

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Marmosets as models of infectious diseases.Frontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jay PetersDepartment of Medicine, University of Texas Health Science Center, San Antonio, Texas, United States of America.ORCID 0000-0002-5230-1062
Diego Jose MaselliDepartment of Medicine, University of Texas Health Science Center, San Antonio, Texas, United States of America.
Mandeep MangatDepartment of Medicine, University of Texas Health Science Center, San Antonio, Texas, United States of America.
Jacqueline J CoalsonDepartment of Medicine, University of Texas Health Science Center, San Antonio, Texas, United States of America.
Cecilia HinojosaDepartment of Medicine, University of Texas Health Science Center, San Antonio, Texas, United States of America.
Luis GiavedoniTexas Biomedical Research Institute, San Antonio, Texas, United States of America.
Barbara A Brown-ElliottDepartment of Microbiology, University of Texas Health Science Center, Tyler, TX, United States of America.
Edward ChanDepartment of Medicine, National Jewish Health, Denver, CO, United States of America.
David GriffithDepartment of Medicine, National Jewish Health, Denver, CO, United States of America.
Texas Biomedical Research Institute · USThe University of Texas Health Science Center at San Antonio · USNational Jewish Health · USThe University of Texas Health Science Center at Tyler · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
NIH HHS P51 OD011133
6 · The paper itself

Abstract

rationaleMycobacterium avium complex, is the most common nontuberculous mycobacterial respiratory pathogen in humans. Disease mechanisms are poorly understood due to the absence of a reliable animal model for M. avium complex pulmonary disease.

objectivesThe objectives of this study were to assess the susceptibility, immunologic and histopathologic responses of the common marmoset (Callithrix jacchus) to M. avium complex pulmonary infection.

methods7 adult female marmosets underwent endobronchial inoculation with 108 colony-forming units of M. intracellulare and were monitored for 30 or 60 days. Chest radiograph was assessed at baseline (prior to infection) and at the time of sacrifice (30 days for 3 animals and 60 days for 4 animals), and bronchoalveolar lavage cytokines, histopathology and cultures of the bronchoalveolar lavage, lungs, liver and kidney were assessed at time of sacrifice. Serum cytokines were monitored at baseline and weekly for 30 days for all animals and at 60 days for those alive. Group differences in serum cytokine measurements between those that tested positive versus negative for the M. intracellulare infection were assessed using a series of linear mixed models. MEASUREMENTS AND MAIN

resultsFive of seven animals (two at 30 days and three at 60 days of infection) had positive lung cultures for M. intracellulare. Extra-pulmonary cultures were positive in three animals. All animals appeared healthy throughout the study. All five animals with positive lung cultures had radiographic changes consistent with pneumonitis. At 30 days, those with M. intracellulare lung infection showed granulomatous inflammation, while at 60 days there were fewer inflammatory changes but bronchiectasis was noted. The cytokine response in the bronchoalveolar lavage fluid was uniformly greater in the animals with positive M. intracellulare cultures than those without a productive infection, with greater levels at 30-days compared to 60-days. Similarly, serum cytokines were more elevated in the animals that had positive M. intracellulare cultures compared to those without a productive infection, peaking 14-21 days after inoculation.

conclusionEndobronchial instillation of M. intracellulare resulted in pulmonary mycobacterial infection in marmosets with a differential immune response, radiographic and histopathologic abnormalities, and an indolent course consistent with M. avium complex lung infection in humans.

Indexed as

Lung DiseasesMycobacterium avium-intracellulare InfectionAdultAnimalsCallithrixCallitrichinaeCytokinesFemaleHumansMycobacterium aviumMycobacterium avium ComplexCytokines

Identifiers

PMID36893126
PMCPMC9997968
OpenAlexW4323652151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.